Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| PRELUDE CAPITAL MANAGEMENT LLC | 05-15-2023 | 03-31-2023 | 1143 | 3,076,080,221 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| NEUBASE THERAPEUTICS INC | COM | 3101 | $57,535 | 311,000 | 0.00 | 0.01 | 0 | 0.00 | 03-31-2023 |
| LARIMAR THERAPEUTICS INC | COM | 3102 | $57,531 | 12,700 | 0.00 | 12,700 | +Inf | 03-31-2023 | |
| DURECT CORP | COM NEW | 3103 | $56,815 | 12,542 | 0.00 | 12,542 | +Inf | 03-31-2023 | |
| ROTH CH ACQUISITION IV CO | *W EXP 07/01/202 | 3104 | $56,380 | 200,000 | 0.00 | 0.00 | 0 | 0.00 | 03-31-2023 |
